AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

MYRIAD GENETICS INC Director's Dealing 2018

Jul 13, 2018

32566_dirs_2018-07-13_f1982ba8-8d1d-4bff-99a5-e3918c88bb74.zip

Director's Dealing

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2018-07-11

Reporting Person: HENDERSON JOHN T (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-07-11	Common Stock	M	10000	$24.39	Acquired	59743	Direct
2018-07-11	Common Stock	S	10000	$44.0	Disposed	49743	Direct
2018-07-11	Common Stock	M	10000	$24.39	Acquired	59743	Direct
2018-07-11	Common Stock	S	10000	$42.0085	Disposed	49743	Direct
2018-07-11	Common Stock	M	10000	$24.39	Acquired	59743	Direct
2018-07-11	Common Stock	S	10000	$40.17	Disposed	49743	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-07-11	Non-Qualified Stock Option (right to buy)	$24.39	M	10000	Disposed	2018-11-13	Common Stock (10000)	Direct
2018-07-11	Non-Qualified Stock Option (right to buy)	$24.39	M	10000	Disposed	2018-11-13	Common Stock (10000)	Direct
2018-07-11	Non-Qualified Stock Option (right to buy)	$24.39	M	10000	Disposed	2018-11-13	Common Stock (10000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	300	Indirect

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.